Patent Office Trials Blog
    • 10/26/2016
      John Bird, a partner in the Washington D.C. office of Sughrue Mion, PLLC will participate in a upcoming webcast entitled, "PTAB Patent Proceedings: Best Practices and Strategies."
    • 9/13/2016
      Sughrue attorneys Michael Dzwonczyk, Chid Iyer and Azy Kokabi along with several codefendants in Eli Lilly and Company et al. v. Accord Healthcare, et al. (S.D. In.), successfully challenged every claim of two Orange Book listed patents in an inter partes review proceeding (IPR) at the U.S. Patent Office. On September 12, 2016, The PTAB found that claims 1-27 of Daiichi Sankyo's and Ube Industries' U.S. Patent No. 8,404,703 and claims 1-26 of U.S. Patent No. 8,569,325 were unpatentable based on prior art that showed every limitation of the challenged claims would have been obvious. Rejecting patent owners' claims that administering a combination of prasugrel and aspirin yielded surprising and unexpected results, the PTAB found that the difference in net clinical benefit between the claims and those of the prior art was merely one of degree, not one in kind.
    • 8/30/2016
      On August 30, 2016, Sughrue has launched its Korean IP Blog, “Hello IP Law," which is aimed to help Korean IP professionals to better understand the U.S. patent law and practice. The blog will release an article every Wednesday.
    • 8/1/2016
      Yoshi Kishimoto published a new book on July 27, 2016 entitled “U.S. Patent Litigation from the Aspect of Intellectual Property Strategies” published by Nikkei Publishing Inc. ( The book discusses two topics: first, intellectual property strategies for improving global industrial competitiveness; second, strategies and practical tips to deal with patent infringement lawsuit in the most litigious nation in the world in both aspects of defense and enforcement of patents. For more information, please contact Sughrue Mion Japan Office at
    More News
    More Events